Select the required product size (default is 5 nmol). [Required]
Step 2
Provide a unique name for your sequence. This name will appear on the product label. [Required]
Step 3
Go to the miRNA database, miRBase[1-4]. Search for your miRNA of interest. You may use the sequencing data in miRBase to help select the appropriate strand to target.
Step 4
Copy the mature sequence and paste into the Sequence box of the IDT® miRNA Inhibitor ordering tool. Keep the sequence format provided in miRBase. The mature miRNA sequence will be automatically converted to an IDT® miRNA Inhibitor when you click Add to Order.
NOTE: The IDT® miRNA Inhibitor sequence will be one nucleotide shorter than the corresponding miRNA sequence.
Step 5
Enter any note or comments about the sequence. This is information for you. IDT does not use this information for manufacturing or ordering purposes.
Step 6
Click Add to Order. You will be taken to the Shopping Cart, where you can review your order.
Bulk Input
Choose a Product:
*The IDT® miRNA Inhibitor sequence will be one nucleotide shorter than the corresponding miRNA sequence.
IDT® miRNA Inhibitors
Disclaimer for Clinical and Diagnostic Applications IDT RUO products are manufactured in accordance with ISO 9001 and are intended for research use only. For clarity, RUO products are not intended for human use, including any clinical or diagnostic applications. If you are interested in using IDT products for clinical applications, please contact IDT application support to learn more about alternative manufacturing services available at IDT.
Find mature miRNA sequences in the miRNA database, miRBase[1-4], and then copy and paste them into the sequence box below.
IDT® miRNA Inhibitors are highly potent and specific microRNA (miRNA) inhibitors designed for functional analysis of miRNAs. They are short, single stranded oligonucleotides comprised of 2’-O-methyl residues with additional ZEN™ modifications. Incorporating 2’-O-methyl residues confers resistance to endonuclease degradation and increases binding affinity to RNA targets, while the ZEN modification blocks exonuclease degradation and further increases binding affinity.